ArticleAmerican journal of preventive cardiology2026
Sex-specific cardiovascular risk prediction using AI-derived epicardial adipose tissue measurements on CT calcium scoring exams.
Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04075162 (Community Benefit of No-charge Calcium Score Screening Program), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Community Benefit of No-charge Calcium Score Screening Program
Who cites it
2 citing papers in PubMed.
- AJPC 2025 in review: A year of growth & clearer mandate for actionable prevention.American journal of preventive cardiology · 2026Article
- Machine learning and multi-omics technologies for precision cardiovascular medicine: advancing diagnosis, risk prediction, and therapeutic guidance.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: The Agatston CAC score from CT-calcium scoring (CTCS) is a standard guideline recommended measure for cardiovascular risk assessment that quantifies calcified plaque burden. However, many studies have reported lower discrimination of CTCS in females. Embedded epicardial adipose tissue (EAT) features have previously been shown to improve prediction of calcium scoring, and we hypothesized that it may provide incremental prognostic information in females. In this study, we evaluate whether integrating epicardial "fat-omics" with CAC score improves major adverse cardiac events (MACE) prediction from CTCS in females and assess the added value of sex-specific modeling. Methods: 40,851 individuals undergoing CTCS for primary prevention (CLARIFY Registry, NCT04075162) were analyzed. MACE was defined as myocardial infarction, stroke, revascularization, or mortality. A validated deep learning model segmented EAT, and 211 "fat-omics" features were extracted. Cox models were trained using CAC score, CAC with fat-omics (EAT-CAC), and sex-specific EAT-CAC models trained. Performance was evaluated on a held-out test set (20 %) using C-index, calibration, and decision curves. Results: The cohort had a mean age of 59.2 years, with 49.4 % females, and 1017 MACE events (2.49 %) over a mean follow-up of 1.7 years. On the test set ( Conclusions: Sex-specific risk models incorporating epicardial fat-omics from CTCS improve risk prediction in females and equity in cardiovascular risk assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.